SmithRx Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 50
Employees
  • Latest Deal Type
  • Debt - PPP
  • Latest Deal Amount
  • $1.25M
Latest Deal Amount
  • Investors
  • 13

SmithRx General Information

Description

Provider of an innovative cloud-based pharmacy benefits platform with a disruptive pass-through pricing model, the company's PBM solution allows seamless integration with platforms used by employers, brokers and third-party administrators. The company's cloud technology and full-stack modular platform provides maximum flexibility, control and visibility of pharmacy benefits data for employer customers and partners. Members benefit from the company's clinical programs, alternative sourcing and transparent pricing to easily manage their prescription benefits and reduce overall drug spend.

Contact Information

Website
www.smithrx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Managed Care
Primary Office
  • 300 Brannan Street
  • Suite 605
  • San Francisco, CA 94107
  • United States
+1 (844) 000-0000

SmithRx Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SmithRx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Debt - PPP 16-Apr-2020 $1.25M 000.00 Completed Generating Revenue
4. Early Stage VC (Series A2) 31-Jul-2018 00.00 000.00 000.00 Completed Generating Revenue
3. Debt - General 01-May-2018 000 0000 Completed Generating Revenue
2. Early Stage VC (Series A) 11-Jan-2018 $9M $12M 0000 Completed Generating Revenue
1. Seed Round 31-Mar-2017 $3M $3M Completed Generating Revenue
To view SmithRx’s complete valuation and funding history, request access »

SmithRx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 6,720,467 $0.000100 $0.11 $1.34 $1.34 1x $1.34 21.6%
To view SmithRx’s complete cap table history, request access »

SmithRx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of an innovative cloud-based pharmacy benefits platform with a disruptive pass-through pricing model, the compa
Enterprise Systems (Healthcare)
San Francisco, CA
50 As of 2021
000.00
000000000 - 000.00

00000000

veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute
00000 0000000000 00000000
Southborough, MA
000 As of 0000
000.00
0000000000 0 000.00

00000000

dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sin
00000 0000000000 00000000
Philadelphia, PA
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SmithRx Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
nirvanaHealth Venture Capital-Backed Southborough, MA 000 000.00 0000000000 0 000.00
000000000 Corporation Philadelphia, PA
00000 Formerly PE-Backed Bensalem, PA 000000&0
000000000000 Private Equity-Backed Watertown, MA 0000 000.00 000000000 000.00
00000000 0000000' Corporate Backed or Acquired Downers Grove, IL 0000 000000&0
You’re viewing 5 of 13 competitors. Get the full list »

SmithRx Executive Team (7)

Name Title Board Seat Contact Info
Jake Frenz Founder & Chief Executive Officer
Darlene Boresch Financial Controller
You’re viewing 2 of 7 executive team members. Get the full list »

SmithRx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SmithRx Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Four Cities Capital Venture Capital Minority 000 0000 000000 0
Kalyan Vepuri Angel (individual) Minority 000 0000 000000 0
MCVC Partners Venture Capital Minority 000 0000 000000 0
Presight Capital Venture Capital Minority 000 0000 000000 0
SciFi VC Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

SmithRx Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 00 10-Jan-2017 000000000000000000 Pharmaceuticals 0000 00000
To view SmithRx’s complete acquisitions history, request access »